Eli Lilly and Company
CL ˙ SNSE ˙ US5324571083
SecurityCL:LLY / Eli Lilly and Company
InstitutionTRUE Private Wealth Advisors
Latest Disclosed Ownership6,898 shares
Latest Disclosed Value $ 6,345,024
TRUE Private Wealth Advisors reports 3.23% decrease in ownership of LLY / Eli Lilly and Company

On May 15, 2026 - TRUE Private Wealth Advisors filed a 13F-HR form disclosing ownership of 6,898 shares of Eli Lilly and Company (CL:LLY) valued at $6,345,024 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 7,128 shares of Eli Lilly and Company. This represents a change in shares of -3.23% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ELI LILLY COM 532457108 6,898 -230 -3.23 6,345 -17.16 0.6048
2026-02-13 2025-12-31 13F ELI LILLY COM 532457108 7,128 -265 -3.58 7,660 35.77 0.7674
2025-11-14 2025-09-30 13F ELI LILLY COM 532457108 7,393 27 0.37 5,641 -1.76 0.5755
2025-08-11 2025-06-30 13F ELI LILLY COM 532457108 7,366 497 7.24 5,742 1.22 0.6452
2025-05-15 2025-03-31 13F ELI LILLY COM 532457108 6,869 26 0.38 5,673 7.40 0.6892
2025-02-13 2024-12-31 13F ELI LILLY COM 532457108 6,843 9 0.13 5,283 -12.77 0.6413
2024-11-14 2024-09-30 13F ELI LILLY COM 532457108 6,834 -1,524 -18.23 6,055 -19.98 0.7224
2024-07-16 2024-06-30 13F ELI LILLY COM 532457108 8,358 -627 -6.98 7,567 8.27 0.8568
2024-04-25 2024-03-31 13F ELI LILLY COM 532457108 8,985 -103 -1.13 6,990 31.94 0.8018
2024-01-30 2023-12-31 13F ELI LILLY COM 532457108 9,088 32 0.35 5,297 8.90 0.6705
2023-11-13 2023-09-30 13F ELI LILLY COM 532457108 9,056 -562 -5.84 4,864 7.85 0.6756
2023-08-11 2023-06-30 13F LILLY ELI COM 532457108 9,618 -1,400 -12.71 4,511 19.22 0.6663
2023-05-11 2023-03-31 13F LILLY ELI COM 532457108 11,018 -811 -6.86 3,784 -12.57 0.5598
2023-02-14 2022-12-31 13F LILLY ELI COM 532457108 11,829 -79 -0.66 4,328 12.39 0.6665
2022-11-04 2022-09-30 13F LILLY ELI CO COM COM 532457108 11,908 155 1.32 3,850 1.05 0.5827
2022-07-28 2022-06-30 13F LILLY ELI CO COM COM 532457108 11,753 670 6.05 3,810 16.59 0.5544
2022-05-09 2022-03-31 13F LILLY ELI CO COM COM 532457108 11,083 16 0.14 3,268 6.90 0.4598
2022-02-11 2021-12-31 13F LILLY ELI CO COM COM 532457108 11,067 15 0.14 3,057 19.74 0.4350
2021-11-05 2021-09-30 13F Eli Lilly and COM 532457108 11,052 -1,163 -9.52 2,553 -8.92 0.3715
2021-08-10 2021-06-30 13F Eli Lilly and COM 532457108 12,215 -29 -0.24 2,803 22.56 0.4164
2021-05-12 2021-03-31 13F Eli Lilly and COM 532457108 12,244 -1,253 -9.28 2,287 0.40 0.3696
2021-01-11 2020-12-31 13F Eli Lilly and COM 532457108 13,497 -84 -0.62 2,278 13.33 0.3817
2020-10-09 2020-09-30 13F Eli Lilly and COM 532457108 13,581 43 0.32 2,010 -9.54 0.3434
2020-07-07 2020-06-30 13F Eli Lilly and COM 532457108 13,538 -3,048 -18.38 2,222 -3.39 0.4065
2020-04-20 2020-03-31 13F Eli Lilly and COM 532457108 16,586 1,444 9.54 2,300 15.58 0.4898
2020-01-27 2019-12-31 13F Eli Lilly and COM 532457108 15,142 -2,000 -11.67 1,990 3.81 0.3051
2019-10-09 2019-09-30 13F Eli Lilly and COM 532457108 17,142 0 0.00 1,917 0.95 0.3311
2019-08-01 2019-06-30 13F Eli Lilly and COM 532457108 17,142 -16 -0.09 1,899 -14.69 0.3235
2019-04-25 2019-03-31 13F Eli Lilly and COM 532457108 17,158 -225 -1.29 2,226 10.69 0.4243
2019-01-14 2018-12-31 13F Eli Lilly and COM 532457108 17,383 -10 -0.06 2,011 -99.89 0.3548
2018-10-18 2018-09-30 13F Eli Lilly and COM 532457108 17,393 48 0.28 1,866,467 126,012.64 0.2627
2018-07-13 2018-06-30 13F Eli Lilly and COM 532457108 17,345 -223 -1.27 1,480 8.90 0.2322
2018-04-25 2018-03-31 13F Eli Lilly and COM 532457108 17,568 -5,760 -24.69 1,359 -31.02 0.2333
2018-01-19 2017-12-31 13F Eli Lilly and COM 532457108 23,328 -394 -1.66 1,970 -2.91 0.3414
2017-10-27 2017-09-30 13F Eli Lilly and COM 532457108 23,722 8,616 57.04 2,029 63.23 0.4571
2017-08-07 2017-06-30 13F Eli Lilly and COM 532457108 15,106 15,106 1,243 0.2881
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.